Profile
Dr. Durand completed an AHA/Bugher Foundation Fellowship in Molecular Biology and Molecular Genetics at Baylor College of Medicine. This led to the discovery of Troponin, one of the first genes for Familial Dilated Cardiomyopathy—one of the most common reasons for heart transplantation in the U.S. His team discovered one of the first genes for Hypertrophic Cardiomyopathy, a gene for sudden cardiac death. Dr. Durand completed a clinical fellowship in Immunology/Advanced Heart Failure/ Circulatory Support and Cardiac Transplantation, and established the world’s first fully integrated Cardiomyopathy/Interventional program at MD Anderson Cancer Center. He speaks internationally about Cardiooncology and cardiovascular complications of anti-cancer therapies and serves as Co- PI on clinical trials for Stem Cell Therapy for Anthracycline-Induced Cardiomyopathy. His current focus is on the recovery of heart function from chemotherapy injury. He is co-chair of the Institutional Review Board at MD Anderson Cancer Center and a certified life coach currently accepting clients.
About Jean-Bernard Durand
Medical School: Wisconsin, Medical College of
Graduation Year: 1988
Professional Webpage: https://faculty.mdanderson.org/profiles/jean-bernard_durand....
Professional Activity:
FACC
FAHA
FCCP
FACP
FHFSA
Community Service:
Board of Directors-L'Alliance Francaise Houston
2000
Other Outstanding Achievements:
University of Texas, MD Anderson Fellowship Award-Faculty of the Year
2017
University of Texas, Department of Cardiology, MD Anderson Cancer Center Best Teacher Award
2013